The introduction of the AffloVest® in 2013 revolutionized the High Frequency Chest Wall Oscillation market by bringing a proven treatment to patients and allowing for mobility during use. The ability for treatment during everyday activities has allowed patients to conduct their therapy while on the go which may led to better, overall patient adherence.
Consistently listening to patient and clinician feedback has allowed Tactile Medical to continuously improve the AffloVest over time and deliver a superior product that patients want to use and clinicians want to prescribe.
A broad range of factors also come into the redesign process. Taking in account varying patient anatomies and ergonomics resulted in offering seven different sizes of the AffloVest to ensure a correct fit for every patient, regardless of their age, height or body type. AffloVest provides patient-specific HFCWO therapy with eight anatomically positioned oscillating motors to create individual pressure waveforms that target all lobes of the lungs, front and back, to loosen, thin and mobilize the patient’s lung secretions.